Status:
COMPLETED
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
Lead Sponsor:
Anahuac University
Conditions:
COVID19
Diabetes Mellitus
Eligibility:
All Genders
30-75 years
Phase:
NA
Brief Summary
The disease caused by SARS-CoV-2, has derived a pandemic in which its evolution and complications depend on the immune capacity of the host. The virus has been characterized by presenting an inflammat...
Detailed Description
Patients in the COVID-19 area, who are treated at the ISSEMYM Toluca Arturo Montiel Rojas Medical Center, located in Paseo Tollocan, Av. Baja Velocidad km 575, Barrio de Sta Clara, Toluca de Lerdo, Mé...
Eligibility Criteria
Inclusion
- Patients admitted to the ISSEMYM Toluca Medical Center "Arturo Montiel Rojas ", diagnosed with COVID-19 confirmed by PCR.
- Patients in need of supplemental O2 with nasal prongs or reservoir-mask for satO2 \<90% and respiratory distress.
- With concomitant diseases such as cardiovascular disease, diabetes mellitus 2, hypertension, overweight or obesity BMI \<35.
- Both sexes.
- Over 30 years old.
- The patient tolerate oral feeding.
- Signing of the letter of informed consent.
Exclusion
- Detachment from treatment.
- Admission to the ICU for any reason.
- Patients who do not tolerate the oral route.
- Reactions to treatment that compromise the health of patients.
Key Trial Info
Start Date :
September 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 10 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04507867
Start Date
September 7 2020
End Date
April 10 2021
Last Update
October 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ISSEMYM "Arturo Montiel Rojas" Medical Center
Toluca, State of Mexico, Mexico, 52140